Press Releases

Clinion Launches CSR Automation to Improve the Speed and Efficiency of Clinical Study Reporting

Perlara partners with Vivan Therapeutics to tackle rare genetic diseases

Today, Perlara PBC, a rare disease public benefit company, has announced a collaboration with Vivan Therapeutics, developers of personalised therapeutics, to identify novel therapeutics for rare genetic diseases.

Sygnature Discovery expands into early CMC development

Sygnature Discovery, a leading Drug Discovery Contract Research Organisation, has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line, located at its headquarters in Nottingham, UK, will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials.

Celemics Partner with Strand Life Science and their StrandOmics Analysis Platform

Dear Nicole, Celemics, a Korea-based biomaterial technology leader that has developed a range of innovative biomaterials and sequencing methods used in the medical, pharmaceutical, microbiome, synthetic biology, and breeding fields, has announced a partnership with Strand Life Sciences, a leading precision medicine informatics company.

ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford

ENPICOM, an innovative bioinformatics software engineering company, has announced the upcoming expansion of the IGX Platform’s capabilities towards advanced liability prediction.

Singapore-UK team to develop a novel device to reduce chemotherapy side-effects

A global team made up of clinicians and scientists working with UK based Paxman has been set up to develop a novel device to reduce chemotherapy side effects — Chemotherapy-induced neuropathy (CIPN).

Community Wellness Announces Partnership with Kentucky Hospital Association

Community Wellness, a leading national provider of Remote Patient Monitoring (RPM) services, has announced a new partnership with the Kentucky Hospital Association (KHA) and their shared services division, KHA Solutions Group.

Quantify Research opens new offices in Denmark and Norway

Quantify Research announces their expansion into Denmark and Norway to expand the breadth and depth of their Nordic service offerings.

3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery

3Brain AG has announced a new technology that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials.

Dolomite Bio’s distributor list expands globally

Dolomite Bio, a company that creates innovative products for high throughput single cell research, has announced the expansion of their current list of distributors.

Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation

Protheragen MedAI Offers Comprehensive Solutions for Drug Research and Development, Medical Imaging and Medical Therapy and Research System

CD Formulation Announces to Optimize Stability Analysis for Drug Pre-formulation Research

Acroscell Develops Drugs Based on Neuropharmacology in Order to Treat Many Different Neurological Diseases

The Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers Greatly Expands Flexibility while Ensuring Reliable Sensitivity in Exploring Diversity of Cellular Immune Responses

Dear Nicole, Immudex ApS, a pioneering life science company spearheading the global adoption of precision immune monitoring, has announced the launch of the new U-Load Dextramer® product line.

MicrobioSeq Introduces Skin Microbiome Solutions to Accelerate Research and Practice

VERICHEM LABORATORIES OFFERS EXTENSIVE LINE OF BIO-SYNTHETIC CLINICAL REFERENCE MATERIALS FOR URINE CHEMISTRIES

VERICHEM now offers clinical laboratorians an extensive line of liquid stable and ready-to-use biosynthetic clinical reference materials for urine chemistry assays.

Takara Bio enters into a license and supply agreement of RetroNectin® with BioNTech Cell & Gene Therapies GmbH

Takara Bio Inc. has announced that it has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech").

IntegrateRNA Develops Customized CircRNA Pull-down Detection Service to Identify The Interaction Between miRNA/RBP and circRNA

Creative Biogene Provides Oligonucleotide Synthesis Services to Promote Research in Genomics and Molecular Biology